Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 12, 158-164, February 1, 1952]
© 1952 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tyner, E. P.
Right arrow Articles by LePage, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tyner, E. P.
Right arrow Articles by LePage, G. A.

In Vivo Studies on Incorporation of Glycine-2-C14 into Proteins and Nucleic Acid Purines*

Evelyn Pease Tyner, Charles Heidelberger and G. A. LePage

( McArdle Memorial Laboratory, The Medical School, University of Wisconsin, Madison 6, Wis.)

A kinetic study was made of the incorporation of glycine-2-C14 into proteins and nucleic acid purines of rat liver and tumor. From the subsequent breakdown of labeled moieties half-times were calculated. Determinations of specific activity of free glycine in the tissues were also carried out.

Isotopic glycine was incorporated into proteins less than 1/2 hour after it was administered by stomach tube. In proteins of liver, Flexner-Jobling carcinoma, and kidney the peaks of specific activity occurred at about 12 hours.

The free purines were isolated from hydrolysates of PNA and DNA by paper chromatography. Radioactivity was first detectable in nucleic acid purines about 1 hour after the administration of glycine. In PNA and DNA purines from liver and tumor, peaks of specific activity occurred at about 24 hours; specific activity of DNA purines was somewhat lower than that of corresponding PNA purines. Nearly identical half-times were found for adenine and guanine in each nucleic acid fraction. Higher specific activities were reached in tumor for purines, in liver in the case of the proteins.

* This work was supported in part by a grant from the American Cancer Society upon recommendation of the Committee on Growth of the National Research Council and by a grant from the Wisconsin Section of the American Cancer Society.

Received 11/29/51.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1952 by the American Association for Cancer Research.